REFERENCES
- Deghady A, Marzouk I, El-Shayeb A, Wali Y. Coagulation abnormalities in type 1 Gaucher disease in children. Pediatr Hematol Oncol 2006; 23: 411–417
- Corrigan JJ. Hemorrhagic and thrombotic diseases: von Willebrand disease. Nelson's Textbook of Pediatrics ed. 15, RE Behrman, RM Kliegman, AM Arvin. WB Saunders, Philadelphia 1996; 1428
- McGovern M M, Desnick R J. Abnormalities of the monocyte-macrophage system: lysosomal storage diseases. Wintrobe's Clinical Hematology, ed. 11, JP Greer, J Foerster, JN Lukens, GM Rodgers, F Paraskevas, B Glader. Lippincott Williams & Wilkins, Philadelphia 2003; 1819–1822
- Billett H H, Rizvi S, Sawitsky A. Coagulation abnormalities in patients with Gaucher's disease: effect of therapy. Am J Hematol 1996; 51: 234–236
- Hollak C E, Levi M, Berends F, Aerts J M, van Oers M H. Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol 1997; 96: 470–476
- Ozturk G, Kocak U, Gursel T, Ezgu F S. Coagulopathy in Gaucher disease. Indian J Pediatr 1998; 65: 771–772